Top Autoimmune Researcher to Lead Cedars-Sinai Institute Skip to main content Close Select your preferred language English عربى 简体中文 繁體中文 فارسي עִברִית 日本語 한국어 Русский Español Tagalog Menu Close Call 1-800-CEDARS-1 toggle search form Close Los Angeles, 18 August 2022 07:08 AM America/Los_Angeles International Leader in Autoimmune Research to Lead Cedars-Sinai Institute Nunzio Bottini, MD, PhD, known for his research into rheumatic diseases, has been selected as the inaugural director of Cedars-Sinai's Kao Autoimmunity Institute. Photo by Cedars-Sinai. Nunzio Bottini, Dr, MD, doctor Nunzio Bottini MD PhD is Inaugural Director of Kao Autoimmunity Institute Nunzio Bottini, MD, PhD, whose groundbreaking research focuses on the role of a group of proteins in the development of rheumatic diseases, has joined Cedars-Sinai as the inaugural director of the Kao Autoimmunity Institute. “Dr. Bottini is an internationally recognized physician-scientist and leader in autoimmune research. He has focused on a group of proteins called phosphatases that are fundamental regulators of inflammation, autoimmunity, and fibrosis. His expertise can help guide Cedars-Sinai in clinical, translational and basic research to advance our understanding of autoimmunity in order to provide the best care for our patients,” said Paul Noble, MD, chair of the Department of Medicine and director of the Women’s Guild Lung Institute. Bottini comes to Cedars-Sinai from the University of California, San Diego (UCSD), where he served as section chief in the Division of Rheumatology, Allergy, and Immunology and as a professor of rheumatology. He received his Doctor of Medicine from the University of Rome in Italy, where he also completed his internship and residency, and fellowship training in rheumatology at UCSD. The Bottini Laboratory at UCSD specialized in the study of a family of signaling enzymes called protein tyrosine phosphatases, implicated in the development of chronic autoimmunity, cancer, and other diseases. “About 24 million adults and children in the United States are afflicted by autoimmune disorders and they are a leading cause of death and disability around the world. At the Kao Autoimmunity Institute, we want to bring top investigators and clinicians together and leverage the culture of scientific excellence and collaboration at Cedars-Sinai to develop novel, evidence based, and personalized treatments, for all human autoimmune diseases” said Bottini. Since 2006, Bottini has been continuously funded by the National Institutes of Health for research that includes rheumatoid arthritis and scleroderma, an autoimmune connective tissue disease that often causes debilitating inflammation in the skin and other areas of the body. “Dr. Bottini is a world-class scientist investigating key mechanisms underpinning rheumatic diseases. His presence and leadership will attract top-level investigators to Cedars-Sinai with the goal of creating one of the nation’s top academic rheumatology programs,” said Francesco Boin, MD, who holds the Cedars-Sinai Chair in Rheumatology and is director of the Scleroderma Center, part of the Kao Autoimmunity Institute. Bottini said he was drawn to Cedars-Sinai for a variety of reasons including the collaborative and interdisciplinary approach to clinical practice and research across the institution and the strong focus on translational medicine. “You can sense the positive energy and see the remarkable commitment of resources, especially at the leadership level, to making a difference in the lives of autoimmune patients. We have a unique opportunity to build a special clinical and research enterprise through the Kao Autoimmunity Institute,” said Bottini. Related Stories RSS feed - Related Stories (opens in new window) View all headlines - Related Stories Positively Battling Scleroderma The Kao Autoimmunity Institute and the Cedars-Sinai Scleroderma Program Mark First Anniversary During Scleroderma Awareness Month June 24, 2021 06:00 AM America/Los_Angeles Scleroderma has taken both of Lovette Twyman Russell's lungs and the tips of three of her fingers, but not one ounce of her joy in life. For the 58-year-old former triathlete, getting the right treatment for this rare autoimmune disease – which … Read more Prominent Rheumatologist to Create Scleroderma Program at Kao Institute Autoimmune Disease Specialist Francesco Boin MD Selected as New Director of the Division of Rheumatology at Cedars-Sinai s New Kao Autoimmunity Institute June 19, 2020 06:00 AM America/Los_Angeles Nationally recognized rheumatology expert Francesco Boin, MD, has been appointed director of the division of Rheumatology and director of the new Scleroderma Program at Cedars-Sinai. Boin is an accomplished and widely published investigator of … Read more My News LA Cedars-Sinai Receives $20 Million Gift January 09, 2020 06:00 AM America/Los_Angeles My News LA recently shared news from Cedars-Sinai about a $20 million gift from Dr. and Mrs. Min H. Kao and the Kao Family Foundation to create the Kao Autoimmunity Institute for advanced research and treatment of rheumatologic diseases.The gift … Read more Show previous items Show next items Contact the Media Team Email: [email protected] Contact Laura Coverson laura.coverson@cshs.org Share this release International Leader in Autoimmune Research to Lead Cedars-Sinai Institute Share on: Twitter Share on: Facebook Share on: LinkedIn Search Our Newsroom Social media Follow us on Twitter (opens in new window) Visit our Facebook page (opens in new window) (opens in new window) Visit our Youtube profile (opens in new window) Latest news 07 Oct 2022 - HealthDay: Black Women Less Likely to Get Laparoscopic Fibroid Surgeries 07 Oct 2022 - Faculty Publications: Sept. 29-Oct. 6 07 Oct 2022 - Fine-Tuning Organ-Chip Technology 06 Oct 2022 - KCRW: Want New Omicron Booster? Wait at Least 2 Months After Last Shot 05 Oct 2022 - Cedars-Sinai Schedules Free Flu Vaccine Clinics 04 Oct 2022 - Cedars-Sinai Showcases Hispanic and Latinx Art Newsroom Home